Wegovy, another FDA-approved weight management medication , functions by mimicking a hormone in the intestines known as GLP-1, which triggers feelings of fullness, thereby helping to reduce appetite and calorie intake
Reddy's submission on April 28, 2026, describing it as the first generic semaglutide authorized by Health Canada and the first to be approved in the G7
At Generation Wellness, we use advanced diagnostics and functional medicine to find the root cause of your fatigue, hormone imbalances, and health concerns
This is accompanied by a complex array of additional features depending on the nature of the lipodystrophy, making this a multisystem disease (2, 4, 6)
RELATED: New GLP-1 drugs could suppress desire for more than just food, study suggests Big picture view: The rapid rise in GLP-1 usage continues to align with broader improvements in national health, particularly aiding in lowering obesity rates